ISODICENTRIC CHROMOSOME-21 - A NOVEL ABERRATION IN ACUTE MYELOID-LEUKEMIA
Citation
M. Sankar et al., ISODICENTRIC CHROMOSOME-21 - A NOVEL ABERRATION IN ACUTE MYELOID-LEUKEMIA, Cancer genetics and cytogenetics, 107(1), 1998, pp. 69-72
Categorie Soggetti
Oncology,"Genetics & Heredity
SICI code
0165-4608(1998)107:1<69:IC-ANA>2.0.ZU;2-J
Abstract
We present here a 78-year-old female patient with acute myeloid leukem
ia (AML), French-American-British classification M2, exhibiting isodic
entric chromosome 21, idic(21)(q22), at the time of diagnosis. The pat
ient had three idic(21)(q22), besides the del(5)(q13q32), add(21)(q22)
, dic(21;22) (q22; q13), and +22. Fluorescence in situ hybridization s
tudies with whole-chromosome painting and centromere-specific probes f
or chromosome 21 verified the diagnosis of idic(21)(q22). There were n
o distinct clinicohematological characteristics of AML with isodicentr
ic 21. The patient was treated with remission-induction therapy follow
ed by consolidation therapy. Two years later, the patient showed the d
isappearance of isodicentric 21 but retained del(5)(q13q32) and gained
other chromosomal abnormalities, +add(17)(p11) and -16. To our knowle
dge, this is the first report of AML with acquired idic(21) (q22). (C)
Elsevier Science Inc., 1998.